161 related articles for article (PubMed ID: 16890860)
1. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study.
Blacher J; Cacoub P; Luizy F; Mourad JJ; Levesque H; Benelbaz J; Michon P; Herrmann MA; Priollet P
J Vasc Surg; 2006 Aug; 44(2):314-8. PubMed ID: 16890860
[TBL] [Abstract][Full Text] [Related]
2. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
[TBL] [Abstract][Full Text] [Related]
3. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
[TBL] [Abstract][Full Text] [Related]
4. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
5. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.
Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D
Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985
[TBL] [Abstract][Full Text] [Related]
6. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
7. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
[TBL] [Abstract][Full Text] [Related]
8. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
[TBL] [Abstract][Full Text] [Related]
9. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
Poredos P; Jezovnik MK
Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
[TBL] [Abstract][Full Text] [Related]
10. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
Conte MS; Bandyk DF; Clowes AW; Moneta GL; Namini H; Seely L
J Vasc Surg; 2005 Sep; 42(3):456-64; discussion 464-5. PubMed ID: 16171587
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.
Al-Omran M
Vasc Health Risk Manag; 2012; 8():349-55. PubMed ID: 22701328
[TBL] [Abstract][Full Text] [Related]
12. Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada.
Kundhal KK; Chin SL; Harrison L; Nowacki B; Doobay B; Titley J; Ciná C; Anand SS
Can J Cardiol; 2007 Apr; 23(5):357-61. PubMed ID: 17440640
[TBL] [Abstract][Full Text] [Related]
13. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
14. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment in peripheral arterial disease: a professional practice study in 262 patients].
Dumas C; Sedighian S; Nangou P; Boukriche Y; Simorre B; Oziol E; Reny JL
Rev Med Interne; 2007 Feb; 28(2):71-8. PubMed ID: 17157964
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
[TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.
Al-Omran M
Vasc Health Risk Manag; 2007; 3(6):1019-27. PubMed ID: 18200820
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
[TBL] [Abstract][Full Text] [Related]
19. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
[TBL] [Abstract][Full Text] [Related]
20. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
